News › Clinical Practice, Industry News, Patient Care

Refine USA’s Rejuvapen NXT Microneedling System Earns FDA Clearance

April 16, 2020

Refine USA has been granted a class 2 medical clearance from the FDA for its medical grade microneedling device, Rejuvapen NXT. This recent clearance has expanded its intended use to facial wrinkles.
The Rejuvapen NXT has passed multiple electrical and safety tests for biocompatibility, including testing for irritation, cytotoxicity and sensitization, ensuring none of the materials used are harmful to the patient. These tests include design verification and validation testing. The product is also certified according to ISO/IEC Guide 17067 and in accordance with ANSI/AAMI ES60601.
Click here to learn more about the Rejuvapen NXT >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Galderma Opens New U.S. and Latin America Headquarters in Miami
    • Raging Agency Becomes Silver Vendor Affiliate with the American Med Spa Association
    • Medical Marketing Whiz Announces Partnership With Boulevard to Help Med Spas and Wellness Clinics Streamline Operations
    • ByrdAdatto Attorneys Recognized in the 2027 Edition of Best Lawyers
    • RHA Redensity Eye Receives FDA Approval for Undereye Hollowing
Advertisement